Trial Profile
A compassionate use program to investigate the efficacy and safety of sofosbuvir and daclatasvir in recurrent Hepatitis C patients after Liver Transplantation.
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 11 Dec 2015
Price :
$35
*
At a glance
- Drugs Daclatasvir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Adverse reactions; Expanded access; Therapeutic Use
- 11 Dec 2015 New trial record